34 results
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications ... sarahthelyon #Diabetes ... #Medications #pharmacology ... #pathophysiology
Drugs for Heart Failure

#medications #chf #pathophysiology #cardiology #pharmacology
Heart Failure #medications ... #chf #pathophysiology ... #cardiology #pharmacology
Diabetes Insipidus vs Syndrome of Inappropriate ADH (SIADH) - Comparison Table

Diabetes Insipidus - Inadequate ADH
SIADH -
Diabetes Insipidus ... Excess ADH #Diabetes ... Comparison #Table #Pathophysiology ... #Signs #Symptoms ... #Diagnosis #Endocrinology
Cardiogenic Shock: Pathogenesis, complications and clinical findings

#Cardiogenic #Shock #pathophysiology #cardiology #diagnosis #signs #symptoms
Cardiogenic #Shock #pathophysiology ... #cardiology #diagnosis ... #signs #symptoms
Mechanisms of Drug-Induced Hyperkalemia 
 • Direct renin inhibitor (Aliskiren)
 • Renin release inhibition (NSAIDs, Beta-Blockers)
#differential #diagnosis ... #pathophysiology ... #pharmacology # ... potassium #medications
Digoxin 101 - Pharmacology
Indications:

1) Tachyarrhythmias 
 • Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardias
 • ↑ Vagal
Digoxin 101 - Pharmacology ... Indications: ... NYHA III or IV symptoms ... thematttsai #Digoxin #Pharmacology ... #cardiology
Selective Serotonin Reuptake Inhibitors: Mechanisms and Side Effects
 • Serotonin Syndrome:
   - Autonomic Hyperactivity:
Serotonin #Inhibitors #Pathophysiology ... #Pharmacology # ... SideEffects #Psychiatry #Diagnosis ... #Signs #Symptoms
Ebstein Anomaly
 • Prevalence
 • Pathophysiology
 • Presentation
 • Physical Examination Findings
 • Initial Management
 •
Prevalence • Pathophysiology ... Ebstein anomaly • Indications ... Ebstein #Anomaly #diagnosis ... #management #cardiology
Serotonin-Norepinephrine Reuptake Inhibitors(SNRIs): Mechanisms and Side Effects

Withdrawal: Dizziness, Diarrhea, Insomnia, Nausea, Vomiting
Serotonin Syndrome - Potentially Life
SerotoninNorepinephrine #Inhibitors #Pathophysiology ... #Pharmacology # ... SideEffects #Psychiatry #Diagnosis ... #Signs #Symptoms
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Inhibitors Increasing Indications ... level < 200 mg/dL Pathophysiology ... #Euglycemic #Diabetic ... Ketoacidosis #EuDKA #diagnosis